A NOVEL FUNCTIONAL CLASSIFICATION OF TP53 GERMLINE VARIANTS: CAN THIS INFORM CANCER SCREENING PRACTICES IN YOUNG CHILDREN?

被引：0
|
作者：
Freycon, Claire [1 ,2 ]
Montellier, Emilie [3 ]
Budd, Crystal [1 ]
Blanchet, Sandrine [3 ]
Tachdjian, Melissa [1 ]
Hainaut, Pierre [3 ]
Goudie, Catherine [1 ,2 ]
机构：
[1] McGill Univ, Res Inst, Child Hlth & Human Dev Dept, Hlth Ctr, Montreal, PQ, Canada
[2] McGill Univ, Div Hematol Oncol, Dept Pediat, Hlth Ctr, Montreal, PQ, Canada
[3] Univ Grenoble Alpes, CNRS, Inst Adv Biosci, Inserm 1209, Grenoble, France
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O198
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [21] TP53 germline mutations in young females with early onset breast cancer in a Mexican population.
    Gallardo, Lenny Nadia
    Tusie-Luna, Teresa
    Tusie-Luna, Maria Isabel
    Diaz-Chavez, Jose
    Medina, Enrique Macario Herrera
    Chavez-Mac Gregor, Mariana
    Rocha, Enrique Bargallo
    Kato, Yayoi Xcchitl Segura
    Villarreal, Cynthia
    Montalvo, Luis Alonso Herrera
    Cantu-de Leon, David Franciso
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Impact of TP53 status and functional classification on molecular profiles in breast cancer subtypes
    Garg, Swati
    Sukhai, Mahadeo A.
    Misyura, Maksym
    Thomas, Mariam
    Zhang, Tong
    Siu, Lillian L.
    Bedard, Philippe L.
    Stockley, Tracy L.
    Kamel-Reid, Suzanne
    CANCER RESEARCH, 2016, 76
  • [23] Cancer surveillance in adults with germline TP53 pathogenic variants: A single-center observational study.
    Meyskens, Thomas
    Vandecaveye, Vincent
    Pans, Steven
    Dresen, Raphaela
    Van Ongeval, Chantal
    Smeets, Ann
    Nevelsteen, Ines
    Neven, Patrick
    Wildiers, Hans
    Schoffski, Patrick
    Denayer, Ellen
    Van Buggenhout, Griet
    Michils, Genevieve
    Brems, Hilde
    Legius, Eric
    Punie, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants
    de Andrade, Kelvin C.
    Strande, Natasha T.
    Kim, Jung
    Haley, Jeremy S.
    Hatton, Jessica N.
    Frone, Megan N.
    Khincha, Payal P.
    Thone, Gretchen M.
    Mirshahi, Uyenlinh L.
    Schneider, Cynthia
    Desai, Heena
    Dove, James T.
    Smelser, Diane T.
    Penn Med Biobank, Penn Medicine
    Regeneron Genetics, Arnold J.
    Levine, Arnold J.
    Maxwell, Kara N.
    Stewart, Douglas R.
    Carey, David J.
    Savage, Sharon A.
    HUMAN GENETICS AND GENOMICS ADVANCES, 2024, 5 (01):
  • [25] Risk of Radiation -Associated Secondary Malignancies among Patients with Breast Cancer Harboring TP53 Germline Variants
    Cederquist, G.
    Boe, L.
    Walsh, M. F.
    Stadler, Z.
    Xu, A. J.
    Mueller, B. A.
    O'Brien, D. A. Roth
    Bernstein, M. B.
    Cuaron, J.
    Bakhoum, S. F.
    Powell, S. N.
    Khan, A. J.
    Robson, M. E.
    Maxwell, K.
    Taunk, N. K.
    Braunstein, L. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S45 - S46
  • [26] Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome
    Abreu, Renata B. V.
    Pereira, Ariane S.
    Rosa, Marcela N.
    Ashton-Prolla, Patricia
    Silva, Viviane A. O.
    Melendez, Matias E.
    Palmero, Edenir I.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines
    Annemarie Koch
    Jiri Hatina
    Harald Rieder
    Hans-Helge Seifert
    Wolfgang Huckenbeck
    Frank Jankowiak
    Andrea R. Florl
    Robert Stoehr
    Wolfgang A. Schulz
    Cellular Oncology, 2012, 35 : 243 - 257
  • [28] Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines
    Koch, Annemarie
    Hatina, Jiri
    Rieder, Harald
    Seifert, Hans-Helge
    Huckenbeck, Wolfgang
    Jankowiak, Frank
    Florl, Andrea R.
    Stoehr, Robert
    Schulz, Wolfgang A.
    CELLULAR ONCOLOGY, 2012, 35 (04) : 243 - 257
  • [29] Prevalence of Germline TP53 Mutations in Young Women with HER2-Positive Breast Cancer.
    Dick, M. G.
    Masciari, S.
    Miron, A.
    Miron, P.
    Foley, K.
    Gelman, R.
    Dillon, D. A.
    Richardson, A. L.
    Verselis, S. J.
    Lypas, G.
    Krop, I. E.
    Garber, J. E.
    CANCER RESEARCH, 2011, 71
  • [30] Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
    Emilia Rogoża-Janiszewska
    Karolina Malińska
    Bohdan Górski
    Rodney J. Scott
    Cezary Cybulski
    Wojciech Kluźniak
    Marcin Lener
    Anna Jakubowska
    Jacek Gronwald
    Tomasz Huzarski
    Jan Lubiński
    Tadeusz Dębniak
    Breast Cancer, 2021, 28 (1) : 226 - 235
12345